Israel’s Oramed announced good results of its Phase 2b trials of ORMD-0801 treatment for Type 2 diabetes. Oramed will now discuss its Phase 3 plans with the US FDA.

https://www.oramed.com/oramed-reports-positive-results-in-the-final-cohort-of-its-phase-2b-oral-insulin-trial/